市場調查報告書

總體基因體學市場增長,趨勢,預測(2020-2025)

Metagenomics Market - Growth, Trends, and Forecasts (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 946291
出版日期 內容資訊 英文 117 Pages
商品交期: 2-3個工作天內
價格
總體基因體學市場增長,趨勢,預測(2020-2025) Metagenomics Market - Growth, Trends, and Forecasts (2020 - 2025)
出版日期: 2020年06月01日內容資訊: 英文 117 Pages
簡介

在預測期內,總體基因體學市場預計將實現6.5%的複合年增長率。研發成本在上升,測序成本在下降,技術進步正在推動市場。此外,對總體基因體學,代謝組學和元蛋白質組學的興趣日益增長,正在推動市場增長。此外,由於DNA測序與總體基因體學緊密相關,因此DNA測序領域的技術進步為總體基因體學市場創造了機遇。此外,人們對病毒性腹瀉,諸如流感,乙型肝炎和艾滋病毒/艾滋病等病毒性疾病以及基因鑑定技術的關注日益增長,這推動了市場的發展。但是,高成本會阻礙市場增長。

本報告調查了總體基因體學市場,並分析了市場概況,市場增長因素和阻礙因素的分析,市場規模以及按產品/技術/應用/地區進行的預測,競爭情況,它提供有關公司概況,市場機會等的全面信息。

內容

第1章簡介

第2章調查方法

第3章執行摘要

第4章市場動態

  • 市場概況
  • 市場增長因素
    • 研發費用增加
    • 降低測序成本
    • 技術進步
  • 市場障礙
    • 高成本
  • 波特的五力分析

第5章市場細分

  • 按產品
    • 測序數據分析服務
    • 試劑盒和試劑
    • 其他
  • 通過技術
    • 順序驅動
    • 功能驅動
  • 通過申請
    • 人類健康
    • 環境
    • 其他
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東/非洲
    • 南美洲

第6章競爭情況

  • 公司簡介
    • Illumina, Inc.
    • QIAGEN
    • Novogene Co., Ltd.
    • PerkinElmer Inc.
    • F. Hoffmann-La Roche Ltd
    • Thermo Fisher Scientific
    • Promega Connections
    • Bio-Rad Laboratories, Inc.
    • Merck KGaA,

第7章市場機會和未來趨勢

目錄
Product Code: 70534

The Metagenomics Market is expected to register a CAGR of 6.5% during the forecast period. This is attributing to increasing R&D expenditure, declining expenses of sequencing, and technological advancements. In addition, the growing interest of researchers in the field of metatranscriptomics, metabolomics, and metaproteomic and investment in bioinformatics to promote metagenomics and microbiome profiling is also some of the factors propelling the growth of the market. Moreover, As DNA sequencing is highly associated with metagenomics so technological advancement in the field of DNA sequencing results in several advantages compared to conventional methods. Some of the advantages are accuracy, reducing the number of presequencing, and attaining authenticity of the sequencing. These advancements in DNA sequencing will create a lucrative opportunity for the metagenomics market. Furthermore, rising concerns related to viral diseases such as virus-induced diarrhea, influenza, hepatitis B, HIV/AIDS, and a growing number of genes identified leading to promote the development of novel metagenome study products and drive the market. However, the high cost of overall metagenomics may hamper the market to a certain extent.

Key Market Trends

Metagenomics in the Environmental is Estimated to Witness a Healthy Growth in Future.

Metagenomics in the environment is estimated to witness healthy growth in the future attributed to advancement in the field of genetic study, high demand among researchers to study microbial ecology, and high adoption in several environmental applications such as crop growth, biofuel production, bioremediation through wastewater treatment and gasoline leaks. Moreover, the growing interest of microbiologists in microbes and the ability of Metagenomics to screen uncultured microbes also promoting the segment growth.

In addition, Metagenomics in human health is also anticipated to show significant growth in the forecasted period due to growing demand among researchers to study the relation between microbes and human diseases. The European Project MetaHIT (metagenomics of human intestinal tract) and the American Human Microbiome Project are some of the research programs working in the field of metagenomics. Moreover, rising investment in the human microbiome and introduction of advanced sequencing technologies leading to drive the metagenomics market.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a significant market share in the global Metagenomics Market due to presence of a large number of pharmaceutical companies focusing on the development of metagenomic workflows, growing research and development expenditure, wide adoption of metagenomics diagnostic, an increasing number of next-generation sequencing (NGS) based research and technological advancements. The United States owns the largest share of the Metagenomics market in the North America region Furthermore, the rapid adoption of novel sequencing technologies and rising awareness about Next Generation Sequencing (NGS) based on metagenomic research is also expected to fuel the Metagenomics Market in this region.

Competitive Landscape

The Metagenomics Market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Illumina, Inc., QIAGEN, Novogene Co., Ltd., PerkinElmer Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Promega Connections, Bio-Rad Laboratories, Inc., and Merck KGaA.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing R&D Expenditure
    • 4.2.2 Declining Expenses of Sequencing
    • 4.2.3 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 High Overall Cost of Metagenomics
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Sequencing & Data Analytics Services
    • 5.1.2 Kits & Reagents
    • 5.1.3 Others
  • 5.2 By Technology
    • 5.2.1 Sequencing Driven
    • 5.2.2 Function Driven
  • 5.3 By Application
    • 5.3.1 Human Health
    • 5.3.2 Environmental
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Illumina, Inc.
    • 6.1.2 QIAGEN
    • 6.1.3 Novogene Co., Ltd.
    • 6.1.4 PerkinElmer Inc.
    • 6.1.5 F. Hoffmann-La Roche Ltd
    • 6.1.6 Thermo Fisher Scientific
    • 6.1.7 Promega Connections
    • 6.1.8 Bio-Rad Laboratories, Inc.
    • 6.1.9 Merck KGaA,

7 MARKET OPPORTUNITIES AND FUTURE TRENDS